The Drug Enforcement Agency has hedged over the side of keeping production of these medicines right down to limit the opportunity for abuse."DEA determined the proposed APQs for amphetamine, lisdexamfetamine and methylphenidate are enough to produce legit healthcare demands, reserve shares, and export requirements for 2024," the agency wrote in a s… Read More